drugset / Trial / NCT01039025
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
To determine the efficacy of high-dose topotecan, cyclophosphamide and melphalan in patients with Multiple Myeloma.
Timeline
- Start
- 2002-02-18
- Primary completion
- 2006-05-19
- Completion
- 2006-05-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 1 g | Intravenous |
| Subject | Melphalan | Small molecule | 70 mg/m2 | Intravenous |
| Subject | Topotecan | Small molecule | 3.5 mg/m2 | Intravenous |